Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antinociceptive interaction between alprazolam and opioids

C G Pick1

  • 1Department of Anatomy and Anthropology, Sackler School of Medicine, Tel Aviv University, Israel. anat03@ccsg.tau.ac.il

Brain Research Bulletin
|January 1, 1997
PubMed
Summary

Alprazolam demonstrates analgesic effects in mice, primarily through a mu-opioid mechanism. Its pain-relieving properties are significantly reduced by mu-opioid antagonists, suggesting a novel pathway for pain management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trazodone and mirtazapine: A possible opioid involvement in their use (at low dose) for sleep?

Medical hypotheses·2019
Same author

Cannabis use during pregnancy: Are we at the verge of defining a "fetal cannabis spectrum disorder"?

Medical hypotheses·2019
Same author

Dietary Energy Restriction Ameliorates Cognitive Impairment in a Mouse Model of Traumatic Brain Injury.

Journal of molecular neuroscience : MN·2019
Same author

Annexin A2, autoimmunity, anxiety and depression.

Journal of autoimmunity·2016
Same author

Post-trauma administration of the pifithrin-α oxygen analog improves histological and functional outcomes after experimental traumatic brain injury.

Experimental neurology·2015
Same author

Mild closed head injury promotes a selective trigeminal hypernociception: implications for the acute emergence of post-traumatic headache.

European journal of pain (London, England)·2014

Area of Science:

  • Pharmacology
  • Neuroscience
  • Pain Research

Background:

  • Alprazolam, a triazolobenzodiazepine, is known for its anxiolytic properties and short half-life.
  • The potential analgesic effects of alprazolam have not been extensively studied.

Purpose of the Study:

  • To investigate the analgesic effects of alprazolam.
  • To determine the mechanism of action underlying alprazolam-induced analgesia, particularly its interaction with the opioid system.

Main Methods:

  • Radiant heat tail-flick assay in mice to measure analgesia.
  • Administration of alprazolam alone and in combination with various opioid receptor antagonists (naloxone, mu, delta, kappa1, kappa3).
  • Competition binding assays to assess alprazolam's affinity for opioid receptor subtypes.

Related Experiment Videos

Main Results:

  • Intrathecal alprazolam produced a dose-dependent increase in tail-flick latency (ED50 = 34 microg).
  • Naloxone significantly blocked alprazolam's analgesic effect, indicating opioid involvement.
  • Mu-opioid antagonists, but not delta or kappa1 antagonists, inhibited alprazolam analgesia.
  • Alprazolam showed the highest affinity for the mu1 opioid receptor subtype in binding assays.

Conclusions:

  • Alprazolam mediates analgesic effects, likely through a mu-opioid mechanism of action.
  • The findings suggest a potential role for alprazolam in pain management via opioid pathways.